Table 4.
The top 10 productive countries of corresponding authors of papers in melanoma immunotherapy between 2010 and 2022.
| Countries | Paper number | Percentage (N/2109) | Total citation | Citation per paper | Top-paper number a | Multiple-country top-paper rate b |
|---|---|---|---|---|---|---|
| USA | 784 | 37.24% | 83240 | 106 | 67 | 52.2% |
| Germany | 191 | 9.07% | 5137 | 26.90 | 3 | 100% |
| China | 157 | 7.46% | 1404 | 8 | 0 | / |
| France | 155 | 7.36% | 15701 | 101.30 | 11 | 72.7% |
| Italy | 119 | 5.65% | 5088 | 42.76 | 4 | 50.0% |
| Japan | 117 | 5.56% | 2009 | 17.17 | 0 | / |
| Australia | 113 | 5.37% | 322 | 29.27 | 4 | 75.0% |
| Netherlands | 62 | 2.95% | 2804 | 45.23 | 3 | 100% |
| United Kingdom | 49 | 2.34% | 8265 | 168.67 | 4 | 100% |
| Canada | 43 | 2.04% | 836 | 19.44 | 0 | / |
a
Besides the countries mentioned above, corresponding authors from Switzerland, Israel, and Sweden contributed two, one, and one top-papers, respectively.
b
Percentage of multiple-country top-papers among all top-papers of a country.
/, Not Applicable.